In a report released today, Terence Flynn from Morgan Stanley reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), with a ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 492.13% and ...

CWA Asset Management Group LLC raised its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 11.9% in ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

We recently compiled a list of the Billionaire Israel Englander’s Top 10 Stock Picks Heading Into 2025. In this article, we ...

Eli Lilly and Company has invested more than $20 billion in its manufacturing capabilities since 2020 to help meet high ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

Chris Schott, an analyst from J.P. Morgan, maintained the Buy rating on Eli Lilly & Co (LLY – Research Report). The associated price target ...

We recently compiled a list of the Jim Cramer Discusses 17 Stocks And Blasts Zero Day Options. In this article, we are going ...

And if a company increases its dividend by just one or two percentage points, that's not even going to offset inflation. On Dec. 9, healthcare giant Eli Lilly announced the approval of a new $15 ...

Like Leqembi, Lilly's Kisunla is designed to clear an Alzheimer ... patients experiencing potentially serious brain swelling, the company said. Additionally, unlike Leqembi, Kisunla has finite ...

As a result, the company gains more resources to boost innovation and still maintain EBITDA growth. Eli Lilly's growth strategy is multi-layered, a mix of in-house innovation and acquisitions and ...